Tandem Diabetes Care (Nasdaq:TNDM) announced today that it made its t:slim mobile app available in a handful of new European countries. The company said on LinkedIn via its International account that it made the app available on both Android and iOS in Germany, Belgium and the Netherlands. San Diego-based Tandem’s t:slim mobile app connects to […]
Diabetes
Dexcom says third party stole, sold scrapped G7 CGM lots
Dexcom (Nasdaq:DXCM) announced today that third parties stole and sold certain G7 continuous glucose monitor (CGM) lots designated as scrap. The company identified the lots — stolen during the destruction process — through ongoing quality and accounting reviews. At this moment, the company reports two G7 lots (1725204004 and 1725069002) as stolen, sold and used by some […]
Beta Bionics earmarks Q2 2027 for Mint patch pump launch, shares details on new tech
Beta Bionics (Nasdaq:BBNX) today provided an update on its expected commercialization timeline for its Mint patch pump system. Irvine, California-based Beta Bionics said it expects to fully commercialize Mint by the end of the second quarter of 2027. This represents an accelerated timeline compared to previous expectations for the end of 2027. The automated insulin […]
New data backs MiniMed 780G pump, SmartGuard algorithm across CGM types
MiniMed (Nasdaq:MMED) today shared findings from a new randomized crossover study backing the use of its 780 automated insulin pump. Findings demonstrated virtually identical glycemic outcomes for users of the pump across two different continuous glucose monitors (CGMs). Investigators published data today in Diabetes Technology & Therapeutics. MiniMed says outcomes reinforce that its automated insulin […]
MiniMed has a new board member following Brett Wall’s Medtronic departure
MiniMed (Nasdaq:MMED) announced the appointment of Scott Cundy to its board of directors, effective July 3, 2026. Cundy’s appointment comes in the wake of Brett Wall’s departure from MiniMed parent company, Medtronic, announced this week. Wall, the EVP and president of the Medtronic Neuroscience portfolio, served as a class II director for MiniMed and as […]
Tandem Diabetes Care terminates chief commercial officer
Tandem Diabetes Care (Nasdaq:TNDM) recently said in an SEC filing that it terminated the employment of chief commercial officer Mark Novara. The SEC Form 8-K, filed on May 15, says that the company notified Novara, an EVP in addition to serving as CCO, on May 11 that his employment was being terminated without cause. The […]
Embecta completes Owen Mumford acquisition
Embecta (Nasdaq:EMBC) announced that it completed its previously announced acquisition of Owen Mumford Holdings Limited. Parsippany, New Jersey-based Embecta completed the deal on Friday, May 15. The former BD Diabetes business agreed to acquire Owen Mumford in March. The deal includes an upfront cash payment of approximately $133 million (£100 million). It also includes an […]
Dexcom launches Flex CGM for type 2 diabetes in Germany
Dexcom (Nasdaq:DXCM) today announced the launch of Dexcom Flex, a new continuous glucose monitor (CGM) for adults with type 2 diabetes. Flex targets adults with type 2 not on intensive insulin therapy, providing an option for those on basal insulin, oral medications or GLP-1 receptor agonists. San Diego–based Dexcom says its new system, set to […]
Dexcom unveils next-gen G8 CGM system, CEO Jake Leach explains new tech
Dexcom (Nasdaq:DXCM) today unveiled its next-generation continuous glucose monitor (CGM), the G8 system, at its Investor Day event. San Diego-based Dexcom CEO Jake Leach previously told Drug Delivery Business News that the G8 would offer a “much smaller wearable” in a step-change from the company’s current-generation G7 system. At the company’s investor day, Leach offered more […]
Glooko wins FDA clearance for cloud-based insulin dosing platform
Glooko announced today that the FDA granted 510(k) clearance for its EndoTool IV Cloud, a cloud-based, patient-specific insulin dosing platform. Palo Alto, California-based Glooko describes the EndoTool IV Cloud as the first FDA-cleared platform of its kind. The cloud-based version of EndoTool IV, it offers a clinical decision support solution for intravenous insulin dosing in […]
